Trial intelligence / Profile preview

Escitalopram effect on cognition and fine motor function in depressed elderly patients

2006-002411-27Phase 4Completed

Sponsor
UPC KU Leuven
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of escitalopram in major depressive disorder (MDD), sponsored by UPC KU Leuven. Primary endpoints: Change in geriatric depression, Change in cognitive functioning and 1 more. Started Sep 2006; status: completed.

02

Drugs

escitalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on 2006-002411-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002411-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call